Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03457935 · ClinicalTrials.gov registry record
Detection of Early Idiopathic Pulmonary Fibrosis
A clinical trial of Idiopathic Pulmonary Fibrosis, sponsored by Temple University.
- Active
- Registry status
- 450
- Enrollment target
- 1
- Study location
NCT03457935 is a study of Idiopathic Pulmonary Fibrosis that is active but no longer recruiting, run by Temple University. The registered enrollment target is 450 participants, below the 743-participant average among 51 other Idiopathic Pulmonary Fibrosis trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03457935, a study of Idiopathic Pulmonary Fibrosis, is active but no longer recruiting, sponsored by Temple University.
- ACTIVE NOT RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine if miR200 family may serve as a biomarker of IPF.
Conditions Studied
Interventions
- OTHER blood samples
Study Locations (1)
Pennsylvania
- Temple University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2018-04-10 |
| Est. Completion | 2026-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03457935
The ClinicalTrials.gov registry entry for NCT03457935 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 743-participant average among 51 other Idiopathic Pulmonary Fibrosis trials with a reported enrollment target (39% lower). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Idiopathic Pulmonary Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which blood samples is the first listed.
NCT03457935 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03457935 about?
NCT03457935 is a clinical study titled "Detection of Early Idiopathic Pulmonary Fibrosis". The purpose of the study is to determine if miR200 family may serve as a biomarker of IPF.
What is the current status of trial NCT03457935?
This trial is currently active not recruiting. The enrollment target is 450 participants. The study started on 2018-04-10. Estimated completion is 2026-08-30.
What conditions does trial NCT03457935 study?
This clinical trial studies the following conditions: Idiopathic Pulmonary Fibrosis.
What interventions are being tested in trial NCT03457935?
The interventions under investigation include: blood samples (OTHER).
Who is sponsoring clinical trial NCT03457935?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03457935 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Idiopathic Pulmonary Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
RECRUITING · Phase 2
-
Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
RECRUITING · Phase 2
-
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
RECRUITING · Early Phase 1
-
Pulmonary Fibrosis Foundation Community Registry
RECRUITING
-
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
RECRUITING · Phase 2
-
Interstitial Lung Disease Research Unit Biobank
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.